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Abstract 
Background Maternal obesity is increasingly prevalent in many westernised countries. Many 
studies report associations between maternal obesity and childhood wheeze or asthma but few 
have considered maternal obesity in relation to respiratory infections or symptoms other than 
wheeze during infancy. This study assesses the relationship between maternal BMI and 
reported wheeze, cough and respiratory infections during the first year of life.  
Methods In 2799 mother-child pairs we examined the relations between maternal pre-
pregnancy BMI and pregnancy weight gain and reported offspring wheeze, prolonged cough, 
lower respiratory tract infection, croup and ear infection before age one year, along with 
reported diarrhoea or vomiting. Maternally-reported paternal BMI was included in the models 
as a proxy for unmeasured confounding by shared familial factors.  
Results Higher maternal BMI was associated with increased risks of offspring wheeze, 
prolonged cough and lower respiratory tract infection (relative risks (95% CI) per 5 kg m-2 
1.09 (1.05-1.13), 1.09 (1.03-1.14) and 1.13 (1.07-1.20), respectively). These associations 
remained after adjusting for maternally-reported paternal BMI. No associations were found 
with croup, ear infection, or diarrhoea or vomiting. Pregnancy weight gain was not associated 
with any of the offspring symptoms or illnesses.  
Discussion Higher maternal BMI is associated with increased risk of wheeze, cough and 
maternally reported lower respiratory tract infection in infancy. These associations were 
independent of maternally-reported paternal BMI. These observations might be explained by 
intrauterine effects of maternal obesity upon respiratory or immune development.  
Abstract Word count: 235
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INTRODUCTION 
Maternal obesity is increasingly prevalent in westernised countries, including the UK, where 
over half of women of child-bearing age are either overweight or obese1. Obesity amongst 
pregnant women has significantly increased over time, with first trimester obesity more than 
doubling from 7.6% during the late 1980s to 15.6% two decades later2. There have been 
multiple reports of increased risk of wheeze3-7, and some of asthma8,9,10, in children born to 
obese mothers. Some studies suggest higher rates of gestational weight gain might also be 
associated with greater childhood wheeze risk11,12. Together these findings suggest maternal 
body composition during pregnancy might affect respiratory or immune development, or 
both. Adverse effects upon the developing immune system or upon infant lung structure and 
function might arise in utero due to inflammatory, metabolic or immunological consequences 
of maternal obesity13. Alternatively, postnatal socioeconomic and lifestyle factors shared 
within families might confound the relationship between maternal obesity and childhood 
wheeze.  
 
We previously found greater maternal fat mass and body mass index (BMI) were associated 
with increased risk of the transient wheeze phenotype but not with atopy, wheeze or asthma 
at age 6 years5. The transient wheeze phenotype is associated with reduced lung function in 
early life and an increased risk of wheeze with respiratory infections during the preschool 
years14. The relative strength of the association with this phenotype suggests maternal obesity 
might be linked to childhood wheeze through adverse effects upon respiratory or immune 
development, leading to reduced lung function, increased susceptibility to infection, or both. 
An association between maternal pre-pregnancy obesity and reduced infant lung function has 
been reported using data from the Wheezing Illnesses Study Leidsche Rijn (WHISTLER)7. 
Whether maternal obesity is also associated with increased susceptibility to infections from 
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early infancy  is less clear, however10. It is not known whether maternal obesity is associated 
specifically with wheeze or also with other respiratory symptoms. Moreover, it is not clear 
whether maternal obesity is associated with increased infections in general or specifically 
with respiratory infections 
 
 
 
This study examined the relationship between maternal pre-pregnancy obesity and illnesses 
during infancy, in particular maternal reports of symptoms and diagnoses associated with 
respiratory infections. The relationship between pregnancy weight gain and these outcomes 
was also examined. Shared familial variables might confound the associations found between 
maternal obesity and childhood respiratory outcomes. Potentially important familial factors 
include diet, physical activity or heritable propensity to obesity. Since factors associated with 
obesity in mothers might also be associated with obesity in fathers paternal BMI was 
considered a suitable proxy for unmeasured confounders influencing the relationship between 
maternal body composition and the risk of wheeze, cough and maternally-reported infections 
during infancy.   
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MATERIALS AND METHODS 
Participants 
Participants were mothers, and children from the Southampton Women’s Survey cohort15. 
The survey recruited women aged 20-34 years during 1998-2002 when they were not 
pregnant. At recruitment, participating women were interviewed and anthropometric 
measurements were made, including height and weight. Women who subsequently became 
pregnant were interviewed at 11 and 34 weeks of pregnancy and childhood follow-up visits 
were scheduled at 6 and 12 months. Twins were excluded from the analysis and only the first 
child born to each woman after recruitment was followed within the study. Of 3158 live 
births, 2823 (89%) were seen at both 6 and 12 months of age (Figure 1). Maternal weights 
and heights were recorded for 2799 (99%) of the women whose children had complete follow 
up. These mother-child pairs formed the analytic sample. Parental consent was obtained and 
local ethics committee approval was granted by the Southampton and South West Hampshire 
Local Research Ethics Committee (LREC Numbers 276/97, 307/97, 089/99).  
 
Anthropometry  
Maternal pre-pregnancy weight and height were measured at recruitment using portable Seca 
scales (Seca Ltd., Birmingham, UK) and Leicester stadiometers (Invicta Plastics Ltd., 
Leicester, UK). BMI was calculated as weight (kg)/(height (m))2. Paternal BMI estimates 
were available for 2445 (87%) of the analytic sample. Paternal BMI was calculated from 
paternal height and weight reported by the mother at 11 weeks of pregnancy. Child’s 
birthweight was measured using Seca scales (Seca Ltd., Birmingham, UK). Subscapular 
skinfold thicknesses were measured at birth and 6 months using Holtain skinfold calipers 
(Holtain Ltd., Dyfed, UK). Subscapular adiposity change conditional upon initial 
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measurements was calculated using regression to account for exact age and for regression to 
the mean.  
 
Childhood illnesses and respiratory symptoms  
At the 6 and 12 month follow-up visits mothers were asked whether their child had suffered 
from either of the following symptoms since the last visit: ‘one or more episodes of chest 
wheezing/whistling’ or ‘waking at night coughing for three or more nights in a row’ 
(prolonged cough). Mothers were also asked if their child had suffered from ‘one or more 
episodes of croup or a croupy cough’, ‘bouts of vomiting or diarrhoea lasting 2 days or 
longer’, or ‘a doctor-diagnosed chest infection’, ‘bronchitis’, ‘bronchiolitis’, ‘pneumonia’ or 
‘ear infection’. Chest infection, bronchitis, bronchiolitis and pneumonia were combined into 
one lower respiratory tract infection (LRTI) variable. Binary variables were created by 
combining responses to the 6 and 12 month questionnaires to indicate whether the child had 
suffered from each outcome during the first year of life. 
 
Statistical methods 
Relative risks for binary outcomes were modelled using Poisson regression with robust 
variance, this being an appropriate method for analysing common outcomes where odds 
ratios cannot be interpreted as relative risks16. Relative risks were expressed per 5 kg m-2 
change in BMI. Analyses were also conducted considering maternal BMI classified according 
to the World Health Organisation scheme as either underweight (BMI < 18.5 kg m-2), normal 
weight (BMI 18.5-24.99 kg m-2), overweight (BMI 25-29.99 kg m-2) or obese (BMI ≥ 30 kg 
m-2); this was considered as both a categorical and continuous predictor in the models. 
Finally, maternal weight gain in pregnancy was classified according to Institute of Medicine 
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categories of weight gain during pregnancy (inadequate, adequate or excessive)17, which are 
defined according to weight gained accounting for pre-pregnancy BMI. 
 
Potential confounders were identified a priori and collected via nurse-administered 
questionnaires. Those considered initially were: maternal age, height, parity, education (this 
closely approximated and was collinear with socioeconomic status based upon occupation), 
late-pregnancy 25-hydroxyvitamin D status, smoking in pregnancy, smoking in child’s 
infancy, and asthma; paternal age, height, and asthma; and child’s birthweight, gestation, age 
at last breastfeed, exposure to smokers in the home other than the mother, and adiposity gain 
between birth and 6 months of age. Potential confounders were included in a directed acyclic 
graph (DAG) to identify the most appropriate adjustment set18; (Figure S1a) this set 
comprised: maternal age, education, parity, and smoking in pregnancy. To account for 
possible unmeasured genetic, environmental and lifestyle factors shared within families 
which might confound the relationship between maternal BMI and infant infections, 
maternally-reported paternal BMI was included in a second model as a descendant of 
unmeasured confounders (Figure S1b).  
 
Our primary aim was to assess the overall impact of maternal obesity. However to assess the 
direct effect of maternal BMI we considered a further model adjusting for potential postnatal 
mediators of the effects of maternal obesity. In this model we adjusted for birthweight and 
adiposity gain in early infancy in addition to the adjustment set identified by the DAG andn 
paternal BMI. Finally, we excluded children born at less than 35 weeks’ gestation in a 
sensitivity analysis to address the possibility of effect modification by gestation. 
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Bonferroni correction was considered over-conservative since the analyses were designed a 
priori to test a limited number of hypotheses and not all the tests were independent19. We 
focused our interest on results with P-values ≤ 0.01 and considered consistency of the 
findings in our interpretation. Stata® 12 (Stata Corp., College Station, TX) was used for all 
analyses. 
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RESULTS 
Participants 
Of the 3158 mother-child pairs in the Southampton Women’s Survey cohort, 2799 had both 
maternal BMI and infant 6 and 12 month follow-up data. These 2799 mother-child pairs were 
included in the analytic sample. Participant mothers had comparable BMIs to those not 
included within the analytic sample. Compared with non-included mothers, those included 
were of higher educational attainment, less likely to smoke in pregnancy and more likely to 
have a history of asthma; included infants were of greater birthweight than those not included 
in the analytic sample (Table 1). Sixty six children were born before 35 weeks’ gestation. The 
median (IQR) period between recruitment and the 11 week pregnancy interview was 1.8 (0.9-
3.1) years. 
 
The median (IQR) maternal BMI measured at recruitment was 24.1 (21.9-27.4) kg m-2; 768 
(27.4%) mothers were classified as overweight and 385 (13.8%) obese. Of the children with 
both 6 and 12 month follow-up data, 1551 (55.5%) experienced respiratory symptoms, 867 
(31.1%) experienced prolonged cough and 1199 (42.9%) wheeze. Respiratory infections were 
reported for 1231 (44.1%) children, with 726 (26.0%) reported to have had a LRTI, 575 
(20.6%) an ear infection and 282 (10.1%) a croupy cough. Vomiting or diarrhoea was 
reported by 1386 (49.6%). 
 
Relationship between maternal BMI and infant respiratory symptoms 
Maternal pre-pregnancy BMI was positively associated with both wheeze and prolonged 
cough in the first year of life (RR per 5 kg m-2, 95%CI 1.10 (1.06-1.14) and (1.10, (1.04-
1.15)), both associations remained significant after adjusting for the relevant confounders 
(Model 1 RR 1.09, (1.05-1.13) and RR 1.09 (1.03-1.14)) and after adjusting for maternally-
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reported paternal BMI in addition to the DAG-identified confounders (Model 2 RR 1.09 
(1.04-1.13) and RR 1.10 (1.04-1.16)) (Table 2). Similar positive associations were found in 
all models when children born before 35 weeks’ gestation were excluded from the analysis 
(RR for wheeze and cough after adjusting for DAG-identified confounders and paternal BMI 
1.08 (1.04-1.13) and 1.10 (1.04-1.17)). Considering maternal BMI as a categorical variable 
reduced the power of the analysis but did not change the direction of effect. Children of obese 
mothers remained at increased risk of wheeze compared with children of mothers of a normal 
weight for height, ((RR 1.19, (1.06-1.34)); the test for trend across the BMI categories was 
significant for wheeze but not for cough (Table 3). The direction of effect was unchanged by 
including maternally-reported paternal BMI within the model (Table 3).  
 
Relationship between maternal BMI and infant illnesses 
Maternal pre-pregnancy BMI was positively associated with LRTI in crude analyses (RR 
1.16, (1.09-1.22)) and after adjustment for both the set of DAG-identified confounders and 
this set plus maternally-reported paternal BMI (RR 1.13, (1.07-1.20) and 1.11, (1.04-1.18), 
respectively) (Table 2). Similar positive associations were found in all models when children 
born before 35 weeks’ gestation were excluded from the analysis (after adjusting for DAG-
identified confounders and paternal BMI RR 1.11 (1.04-1.18)). There were no significant 
associations between maternal BMI and croup or ear infection during the first year of life and 
no linear association with diarrhoea or vomiting. Considering BMI as a categorical variable 
did not change these results; compared with children born to mothers of normal BMI the 
relative risk of LRTI in the first year of life for children of obese mothers was 1.30 (1.10-
1.53) and there was a significant trend across BMI categories (Table 3). Maternal overweight 
and maternal obesity were positively associated with prolonged cough, but failed to meet 
significance (p≤0.01). There was an isolated association between maternal overweight but not 
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obesity and diarrhoea or vomiting. The direction of these effects persisted after including 
maternally-reported paternal BMI in the model (Table 4). 
 
Relationship between maternal weight gain in pregnancy and infant symptoms and 
infections 
No associations were found between maternal weight gain in pregnancy and risk of 
symptoms or infections during infancy in either the full cohort (Table 4) or after excluding 
children born before 35 weeks’ gestation (data not shown). Neither inadequate nor excessive 
weight gain was associated with  risk significantly different from that of infants born to 
mothers with adequate weight gain. 
Contribution of postnatal mediators 
Significant positive associations were found between maternal BMI and infant wheeze, 
persistent cough and LRTI in an alternative model which adjusted for postnatal factors 
potentially mediating the effects of maternal obesity. After adjusting for the DAG-identified 
confounders, paternal BMI, child’s birthweight and adiposity gain during infancy the relative 
risks for wheeze, cough and LRTI were respectively 1.09 (1.05-1.14), 1.11 (1.05-1.18) and 
1.11 (1.04-1.18). 
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DISCUSSION 
This study found greater maternal pre-pregnancy BMI to be associated with increased risk of 
maternally reported wheeze, cough and LRTI in the first year of life. These associations 
persisted after adjustment for maternal age, education, parity, and smoking in pregnancy, and 
also after adjustment for maternally-reported paternal BMI as a proxy for unmeasured shared 
familial confounding. The associations found between maternal BMI and maternally reported 
infections were minimally diminished by inclusion of potential postnatal mediators and are 
consistent with maternal obesity acting in utero to adversely affect respiratory or immune 
development, or both.  
 
Guidelines from both the National Institute for Health and Care Excellence and the Royal 
College of Obstetricians and Gynaecologists recommend that women who are obese should 
be encouraged to lose weight before becoming pregnant in order to benefit their own health 
and that of their child20,21. This study extends the findings of previous studies reporting 
increased childhood wheeze risk in association with greater maternal BMI and provides 
further support for these recommendations. Of the many studies which have found 
associations between higher maternal BMI and increased childhood wheeze, most reported 
wheeze during infancy3,22, or during the preschool years4,6,23, periods when wheezing is 
frequently triggered by respiratory infections and may not persist. A smaller number of 
studies reported associations between maternal obesity and wheeze at school age9,12, or 
during adolescence8, when wheezing is more likely to be a feature of asthma. The 
mechanisms underlying these associations are unclear, although notably our previous study 
did not support anassociation between maternal obesity and atopy5. 
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Few studies have considered the relationship between maternal obesity and symptoms other 
than wheeze or investigated respiratory infections as an outcome. An obesogenic maternal 
diet, that is one high in carbohydrates but low in fruits and vegetables, has been linked with 
increased risk of life-threatening respiratory syncytial virus infection24. Moreover, a registry 
study has shown that maternal pre-pregnancy obesity is associated with a higher rate of 
admission for any respiratory diagnosis between birth and five years of age25. Although 
respiratory infections are a common cause of admission in this age range, the outcome was 
not restricted to infections and included non-infectious outcomes, including asthma, and 
diagnoses, such as hypoxemia and need for mechanical ventilation, which might arise as a 
consequence of significant illness of non-respiratory origin. The MoBa prospective cohort 
has, however, considered the risk of respiratory tract infection separately from that of 
wheeze, or other respiratory symptoms or diagnoses . Mothers in the MoBa study were asked 
to recall episodes of respiratory syncytial-virus, bronchiolitis, bronchitis or pneumonia 
between birth and 6 months and between 6 and 18 months. In contrast to our findings, 
although maternal obesity was related to maternally-reported LRTI in crude analyses, this 
association did not remain after adjusting for lifestyle and socioeconomic characteristics3. 
Differences in outcome reporting and classification, particularly with respect to age of 
assessment, might underlie the differences between this study and the MoBa study results. 
Moreover maternal anthropometry was reported rather than measured in the MoBa study 
which might have led to inaccuracy and weakening of any association. 
 
There is mounting evidence to suggest that obese individuals are at increased risk of 
respiratory infection. During the 2009 H1N1 influenza pandemic, obese individuals were 
found to be more susceptible and to suffer more severe outcomes than those of normal 
weight26. Data linkage27 and prospective cohort studies28 have shown obese adults to be at 
15 
 
increased risk of community-acquired pneumonia and there is also evidence that childhood 
obesity is associated with increased respiratory infections29. Mechanisms proposed to explain 
these associations include: mechanical effects of obesity, including increased risk of gastro-
oesophageal reflux and aspiration, and effects of inflammatory mediators produced by 
adipose tissue 30. Inflammatory mechanisms might also mediate intergenerational effects of 
an obesogenic diet or of maternal obesity upon offspring development and later health. 
Alternatively, epigenetic effects, or changes to maternal or infant microbiomes might be 
responsible for the developmental consequences of maternal diet and body composition31,32. 
 
In utero exposure to inflammatory states, such as chorioamnionitis and smoking, has been 
associated with both infant respiratory illness and childhood asthma33,34. Inflammatory 
mechanisms might also underlie the associations with maternal obesity since obese pregnant 
women have higher levels of proinflammatory cytokines in their serum and amniotic fluid 
than pregnant women of normal weight35,36. The Tucson Infant Immune Study reported that 
children of mothers in the highest third of pregnancy weight gain were at increased risk of 
developing asthma and had persistently elevated TNF-α in early life11, suggesting prenatal 
influences might, indeed, affect fetal immune development.  
 
An alternative explanation for the associations we found could be that maternal obesity 
adversely affects lower airway development. Alterations in airway branching, compliance or 
calibre might predispose either to an increased risk of respiratory infection or to more severe 
and clinically apparent symptoms during episodes of respiratory infection. Developmental 
effects might affect the function of the smaller airways of the lower respiratory tract in 
particular due to the inverse relationship between airway resistance and airway radius. An 
effect upon the lower airway structure might occur independently from immune effects or 
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increased vulnerability to infection per se. This is supported by our findings that other 
infections (croup, ear infection, and diarrhoea or vomiting) showed no associations with 
maternal obesity. This is also consistent with the WHISTLER study’s finding of decreased 
lung function in infants born to obese mothers7. Maternal obesity might be linked to 
structural change in the respiratory system by increased secretion of adipokines such as 
leptin. Leptin receptors are expressed in the lung37, leptin regulates fetal lung cell 
maturation38, and leptin levels have been shown to be inversely related to forced expiratory 
volume in children39. 
 
This study’s strength lies in the measurement of maternal BMI in a longitudinal birth-cohort 
where many potential confounders are measured and maternally-reported paternal BMI 
serves as a proxy for unmeasured familial confounders. There was high participant retention 
within this study and maternal BMI did not differ significantly between participants and non-
participants. The study has some limitations. Despite the high retention rate the number of 
women in the obese category was low which may have reduced the power to detect 
associations when considering BMI categories. This approach also increases the chance of 
type I error which might explain the isolated association between maternal overweight dn 
diarrhoea or vomiting, although this requires investigation in further cohorts. Infant 
symptoms, illnesses and infections were reported by the mother without laboratory 
confirmation of infections and could potentially be subject to bias. It is possible that mothers 
of higher BMI status are more likely to recognise4 or report respiratory infections in their 
children. . Inclusion of a range of covariates, such as maternal education and smoking, within 
the adjusted models should help to reduce this potential bias, although it cannot be entirely 
ruled out. Paternal BMI was calculated from weight and height estimates reported by mothers 
questioned at 11 weeks of pregnancy. Although this is unlikely to be as accurate as measured 
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values, many fathers are likely to have been present when the 11 week questionnaire was 
administered and therefore able to confirm the estimated measurements. Since maternal BMI 
was calculated from weight and height measured at recruitment, for some women, 
particularly those becoming pregnant later in follow up, these measurements could have been 
some years before pregnancy and potentially unrepresentative of BMI immediately 
prepregnancy. Potential misclassification of BMI would tend to bias the findings towards the 
null hypothesis. This means that the significant associations found with maternal BMI might 
underestimate the effect of maternal obesity. Finally, it is possible that the potentially lesser 
accuracy of the maternally-reported paternal BMI variable reduces its value as a proxy for 
unmeasured confounders.  
 
In conclusion, we found that greater maternal BMI is associated with increased risk of cough, 
wheeze and lower respiratory tract infection in infancy. These associations remained after 
including paternal BMI in the model and the postnatal mediators birthweight and infant 
adiposity gain. Whilst these associations might still reflect unmeasured confounders, 
intrauterine effects of maternal obesity upon immune or respiratory development might also 
explain these observations. 
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Table 1 Comparison of SWS mother-child pairs included in the analysis compared with those 
not included because of either incomplete follow up at 6 or 12 months or missing maternal 
BMI data. 
 Participating 
mother-child pairs 
(n=2799) 
Mother-child 
pairs with missing 
data (n=359) 
P-value 
Maternal characteristics    
Age at child’s birth, years (mean 
(SD)) 
30.7 (3.8) 30.6 (4.0) 0.8 
Height, cm (mean (SD)) 163.3 (6.5) 162.7 (6.4) 0.2 
Primiparous (n (%))    
No 1445 (51.7) 167 (46.7) 0.07 
Yes 1352 (48.3) 191 (53.4)  
Qualifications 
(n (%)) 
None  81 (2.9) 18 (5.0) 0.02 
GCSE D-G 252 (9.0) 43 (12.0)  
GCSE A*-C 810 (29.0) 101 (28.2)  
 A Level 845 (30.3) 108 (30.2)  
 HND 183 (6.6) 15 (4.2)  
 Degree 620 (22.2) 73 (20.4)  
Smoked in pregnancy (n (%))    
No 2278 (84.5) 227 (77.2) 0.001 
Yes 418 (15.5) 67 (22.8)  
Maternal asthma (n (%))    
No 1949 (77.2) 243 (82.9) 0.03 
Yes 576 (22.8) 50 (17.1)  
Measured maternal BMI, kgm-2 
(median, (IQR)) 
24.1 (21.9, 27.4) 24.4 (21.7, 27.5) 0.8 
Paternal characteristics    
Age at child’s birth, years (mean 
(SD)) 
33.2 (5.4) 33.0 (5.7) 0.5 
Height, cm (mean (SD)) 179.1 (7.3) 178.6 (6.8) 0.2 
Paternal asthma (n (%))    
No 2031 (81.3) 242 (84.0) 0.3 
Yes 466 (18.7) 46 (16.0)  
Paternal BMI, kg m-2 (median (IQR) 25.5 (23.5, 27.8) 25.5 (23.4, 27.6) 0.9 
Child’s characteristics    
Gender (n (%))    
Male  1445 (51.6) 188 (53.1) 0.6 
Female 1354 (48.4) 166 (46.9)  
Birth weight, kg (mean (SD)) 3441 (547) 3230 (676) 0.005 
Gestational age, weeks (median 40.0 (39.1, 41.0) 39.9 (38.9, 41.0) 0.08 
(IQR)) 
Numbers do not always add to the full column totals due to missing data 
Binary outcomes were compared by χ2 test, categorical outcomes by a χ2 test for trend, and 
continuous variables using t-tests, after transformation where appropriate, or a Mann-
Whitney U-test. 
Table 2 Relationship between maternal pre-pregnancy BMI and maternally-reported symptoms and infections during the first year of life 
Outcome Unadjusted Model 1 Model 2 
 
RR (95% CI) P-value N RR (95% CI) P-value N RR (95% CI) P-value N 
Wheeze 1.10 (1.06, 1.14) <0.0001 2793 1.09 (1.05, 1.13) <0.0001 2682 1.09 (1.04, 1.13) 0.0001 2382 
Prolonged cough 1.10 (1.04, 1.15) 0.0007 2792 1.09 (1.03, 1.14) 0.003 2681 1.10 (1.04, 1.16) 0.001 2381 
LRTI 1.16 (1.09,1.22) <0.0001 2795 1.13 (1.07, 1.20) <0.0001 2684 1.11 (1.04, 1.18) 0.001 2384 
Croup 1.01 (0.90, 1.14) 0.8 2796 1.01 (0.90, 1.14) 0.8 2685 0.99 (0.86, 1.13) 0.8 2385 
Ear infection 1.04 (0.97, 1.12) 0.3 2795 1.04 (0.96, 1.11) 0.4 2684 1.03 (0.95, 1.11) 0.5 2385 
Diarrhoea/vomiting 1.03 (0.99, 1.07) 0.1 2796 1.03 (1.00, 1.08) 0.08 2685 1.02 (0.98, 1.06) 0.3 2384 
Model 1 adjusts for DAG-identified confounders (maternal age, education, parity, and smoking in pregnancy) whilst Model 2 adjusts for these confounders 
plus paternal BMI. 
Table 3 Relationship between maternal pre-pregnancy BMI category and maternally-reported symptoms and infections during the first year of 
life  
BMI category RR (95% CI) P-value RR (95% CI) P-value RR (95% CI) P-value RR (95% CI) P-value RR (95% CI) P-value RR (95% CI) P-value 
 Wheeze Prolonged cough LRTI Croup Ear infection Diarrhoea / vomiting 
 Adjusting for DAG-identified confounders (Model 1 - maternal age, education, parity, smoking in pregnancy) 
Underweight 0.70 (0.44, 1.11) 0.1 1.09 (0.71, 1.68) 0.7 0.71 (0.38, 1.34) 0.3 1.58 (0.79, 3.15) 0.2 0.83 (0.44, 1.54) 0.5 1.00 (0.74, 1.35) 0.99 
Normal Reference            
Overweight 1.08 (0.98, 1.20) 0.1 1.16 (1.02, 1.32) 0.02 1.12 (0.96, 1.29) 0.1 1.04 (0.80, 1.35) 0.8 0.99 (0.83, 1.18) 0.9 1.17 (1.07, 1.27) <0.001 
Obese 1.19 (1.06, 1.34) 0.003 1.14 (0.97, 1.35) 0.1 1.30 (1.10, 1.53) 0.002 1.07 (0.77, 1.49) 0.7 1.05 (0.85, 1.30) 0.7 1.05(0.93, 1.18) 0.4 
p-trend  0.001  0.04  0.001  0.9  0.6  0.04 
 Adjusting for DAG-identified confounders and paternal BMI (Model 2 – paternal BMI, maternal age, education, parity, smoking in pregnancy) 
Underweight 0.71 (0.44, 1.15) 0.2 0.94 (0.56, 1.55) 0.8 0.79 (0.42, 1.47) 0.5 1.21 (0.53, 2.77) 0.7 0.77 (0.39, 1.52) 0.5 0.97 (0.70, 1.33) 0.8 
Normal Reference            
Overweight 1.11 (0.99, 1.23) 0.06 1.18 (1.03, 1.35) 0.01 1.09 (0.94, 1.28) 0.3 0.96 (0.72, 1.29) 0.8 1.01 (0.84, 1.21) 0.9 1.15 (1.06, 1.26) 0.002 
Obese 1.19 (1.05, 1.35) 0.007 1.17 (0.98, 1.38) 0.08 1.23 (1.03, 1.48) 0.02 1.03 (0.72, 1.46) 0.9 0.98 (0.78, 1.24) 0.9 1.00(0.88, 1.14) 0.98 
p-trend  0.001  0.02  0.01   0.9 0.9  0.2 
 
Table 4 Relationship between maternal weight gain in pregnancy and maternally-reported symptoms and infections during the first year of life 
adjusting for the minimum adjustment set 
Institute of 
Medicine Weight 
gain in pregnancy 
category 
RR (95% CI) P-value RR (95% CI) P-value RR (95% CI) P-value 
 Wheeze  Prolonged cough  LRTI  
Inadequate 1.05 (0.92, 1.19) 0.4 0.93 (0.78, 1.11) 0.4 1.03 (0.86, 1.24) 0.7 
Adequate Reference        
Excessive 0.97 (0.87, 1.09) 0.6 0.99 (0.86, 1.15) 0.9 0.93 (0.79, 1.09) 0.3 
 Croup  Ear infection  Vomiting or diarrhoea  
Inadequate 1.17 (0.85, 1.61) 0.3 0.94 (0.74, 1.18) 0.6 1.01 (0.90, 1.14) 0.9 
Adequate Reference        
Excessive 0.86 (0.64, 1.15) 0.3 1.14 (0.95, 1.38) 0. 2 1.05 (0.96, 1.16) 0.3 
DAG-identified confounders maternal age, education, parity, and smoking in pregnancy 
 
